blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2753684

EP2753684 - A MULTILEVEL ANALYTE ASSAY [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.07.2020
Database last updated on 02.09.2024
FormerThe patent has been granted
Status updated on  28.06.2019
FormerGrant of patent is intended
Status updated on  18.02.2019
FormerExamination is in progress
Status updated on  09.12.2016
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Nexus Dx, Inc.
6759 Mesa Ridge Road, Suite 100
San Diego, CA 92121 / US
[2014/29]
Inventor(s)01 / BRENNAN, Ed
6759 Mesa Ridge Road
Suite 100
San Diego, California 92121 / US
02 / LI, Conan
6759 Mesa Ridge Road
Suite 100
San Diego, California 92121 / US
03 / BELENKY, Alexander
6759 Mesa Ridge Road
Suite 100
San Diego, California 92121 / US
 [2014/29]
Representative(s)CMS Cameron McKenna Nabarro Olswang LLP
Cannon Place
78 Cannon Street
London EC4N 6AF / GB
[2019/31]
Former [2014/29]Hollywood, Jane Constance
Olswang LLP
90 High Holborn
London WC1V 6XX / GB
Application number, filing date12829917.910.09.2012
[2019/31]
WO2012US54425
Priority number, dateUS201161532433P08.09.2011         Original published format: US 201161532433 P
[2014/29]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013036913
Date:14.03.2013
Language:EN
[2013/11]
Type: A1 Application with search report 
No.:EP2753684
Date:16.07.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 14.03.2013 takes the place of the publication of the European patent application.
[2014/29]
Type: B1 Patent specification 
No.:EP2753684
Date:31.07.2019
Language:EN
[2019/31]
Search report(s)International search report - published on:US14.03.2013
(Supplementary) European search report - dispatched on:EP28.07.2015
ClassificationIPC:C12M1/34
[2014/29]
CPC:
G01N33/54386 (EP,CN); G01N33/6893 (US); G01N33/54389 (US);
G01N33/6887 (US); G01N2333/4712 (US); G01N2800/324 (EP,CN,US);
G01N2800/325 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/29]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:MEHRSTUFIGES ANALYT-ASSAY[2014/29]
English:A MULTILEVEL ANALYTE ASSAY[2014/29]
French:DOSAGE DE SUBSTANCE À ANALYSER À PLUSIEURS NIVEAUX[2014/29]
Entry into regional phase07.03.2014National basic fee paid 
07.03.2014Search fee paid 
07.03.2014Designation fee(s) paid 
07.03.2014Examination fee paid 
Examination procedure07.03.2014Examination requested  [2014/29]
18.02.2016Amendment by applicant (claims and/or description)
27.05.2016Despatch of a communication from the examining division (Time limit: M06)
06.12.2016Reply to a communication from the examining division
06.07.2017Despatch of a communication from the examining division (Time limit: M06)
12.01.2018Reply to a communication from the examining division
10.01.2019Cancellation of oral proceeding that was planned for 11.01.2019
11.01.2019Date of oral proceedings (cancelled)
19.02.2019Communication of intention to grant the patent
18.06.2019Fee for grant paid
18.06.2019Fee for publishing/printing paid
18.06.2019Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  27.05.2016
Opposition(s)03.06.2020No opposition filed within time limit [2020/33]
Fees paidRenewal fee
12.09.2014Renewal fee patent year 03
11.09.2015Renewal fee patent year 04
13.09.2016Renewal fee patent year 05
12.09.2017Renewal fee patent year 06
11.09.2018Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU10.09.2012
AL31.07.2019
AT31.07.2019
CY31.07.2019
CZ31.07.2019
DK31.07.2019
EE31.07.2019
ES31.07.2019
FI31.07.2019
HR31.07.2019
IT31.07.2019
LT31.07.2019
LV31.07.2019
MC31.07.2019
MK31.07.2019
MT31.07.2019
NL31.07.2019
PL31.07.2019
RO31.07.2019
RS31.07.2019
SE31.07.2019
SI31.07.2019
SK31.07.2019
SM31.07.2019
TR31.07.2019
IE10.09.2019
LU10.09.2019
BE30.09.2019
CH30.09.2019
LI30.09.2019
IS30.10.2019
BG31.10.2019
NO31.10.2019
GR01.11.2019
PT02.12.2019
[2022/31]
Former [2021/34]HU10.09.2012
AL31.07.2019
AT31.07.2019
CY31.07.2019
CZ31.07.2019
DK31.07.2019
EE31.07.2019
ES31.07.2019
FI31.07.2019
HR31.07.2019
IT31.07.2019
LT31.07.2019
LV31.07.2019
MC31.07.2019
MT31.07.2019
NL31.07.2019
PL31.07.2019
RO31.07.2019
RS31.07.2019
SE31.07.2019
SI31.07.2019
SK31.07.2019
SM31.07.2019
TR31.07.2019
IE10.09.2019
LU10.09.2019
BE30.09.2019
CH30.09.2019
LI30.09.2019
IS30.10.2019
BG31.10.2019
NO31.10.2019
GR01.11.2019
PT02.12.2019
Former [2021/32]HU10.09.2012
AL31.07.2019
AT31.07.2019
CY31.07.2019
CZ31.07.2019
DK31.07.2019
EE31.07.2019
ES31.07.2019
FI31.07.2019
HR31.07.2019
IT31.07.2019
LT31.07.2019
LV31.07.2019
MC31.07.2019
NL31.07.2019
PL31.07.2019
RO31.07.2019
RS31.07.2019
SE31.07.2019
SI31.07.2019
SK31.07.2019
SM31.07.2019
TR31.07.2019
IE10.09.2019
LU10.09.2019
BE30.09.2019
CH30.09.2019
LI30.09.2019
IS30.10.2019
BG31.10.2019
NO31.10.2019
GR01.11.2019
PT02.12.2019
Former [2021/26]AL31.07.2019
AT31.07.2019
CY31.07.2019
CZ31.07.2019
DK31.07.2019
EE31.07.2019
ES31.07.2019
FI31.07.2019
HR31.07.2019
IT31.07.2019
LT31.07.2019
LV31.07.2019
MC31.07.2019
NL31.07.2019
PL31.07.2019
RO31.07.2019
RS31.07.2019
SE31.07.2019
SI31.07.2019
SK31.07.2019
SM31.07.2019
TR31.07.2019
IE10.09.2019
LU10.09.2019
BE30.09.2019
CH30.09.2019
LI30.09.2019
IS30.10.2019
BG31.10.2019
NO31.10.2019
GR01.11.2019
PT02.12.2019
Former [2020/37]AL31.07.2019
AT31.07.2019
CZ31.07.2019
DK31.07.2019
EE31.07.2019
ES31.07.2019
FI31.07.2019
HR31.07.2019
IT31.07.2019
LT31.07.2019
LV31.07.2019
MC31.07.2019
NL31.07.2019
PL31.07.2019
RO31.07.2019
RS31.07.2019
SE31.07.2019
SI31.07.2019
SK31.07.2019
SM31.07.2019
TR31.07.2019
IE10.09.2019
LU10.09.2019
BE30.09.2019
CH30.09.2019
LI30.09.2019
IS30.10.2019
BG31.10.2019
NO31.10.2019
GR01.11.2019
PT02.12.2019
Former [2020/36]AL31.07.2019
AT31.07.2019
CZ31.07.2019
DK31.07.2019
EE31.07.2019
ES31.07.2019
FI31.07.2019
HR31.07.2019
IT31.07.2019
LT31.07.2019
LV31.07.2019
MC31.07.2019
NL31.07.2019
PL31.07.2019
RO31.07.2019
RS31.07.2019
SE31.07.2019
SK31.07.2019
SM31.07.2019
TR31.07.2019
IE10.09.2019
LU10.09.2019
CH30.09.2019
LI30.09.2019
IS30.10.2019
BG31.10.2019
NO31.10.2019
GR01.11.2019
PT02.12.2019
Former [2020/35]AL31.07.2019
AT31.07.2019
CZ31.07.2019
DK31.07.2019
EE31.07.2019
ES31.07.2019
FI31.07.2019
HR31.07.2019
IT31.07.2019
LT31.07.2019
LV31.07.2019
MC31.07.2019
NL31.07.2019
PL31.07.2019
RO31.07.2019
RS31.07.2019
SE31.07.2019
SK31.07.2019
SM31.07.2019
TR31.07.2019
LU10.09.2019
CH30.09.2019
LI30.09.2019
BG31.10.2019
NO31.10.2019
GR01.11.2019
PT02.12.2019
IS24.02.2020
Former [2020/34]AL31.07.2019
AT31.07.2019
CZ31.07.2019
DK31.07.2019
EE31.07.2019
ES31.07.2019
FI31.07.2019
HR31.07.2019
IT31.07.2019
LT31.07.2019
LV31.07.2019
MC31.07.2019
NL31.07.2019
PL31.07.2019
RO31.07.2019
RS31.07.2019
SE31.07.2019
SK31.07.2019
SM31.07.2019
TR31.07.2019
CH30.09.2019
LI30.09.2019
BG31.10.2019
NO31.10.2019
GR01.11.2019
PT02.12.2019
IS24.02.2020
Former [2020/27]AL31.07.2019
AT31.07.2019
CZ31.07.2019
DK31.07.2019
EE31.07.2019
ES31.07.2019
FI31.07.2019
HR31.07.2019
IT31.07.2019
LT31.07.2019
LV31.07.2019
MC31.07.2019
NL31.07.2019
PL31.07.2019
RO31.07.2019
RS31.07.2019
SE31.07.2019
SK31.07.2019
SM31.07.2019
TR31.07.2019
BG31.10.2019
NO31.10.2019
GR01.11.2019
PT02.12.2019
IS24.02.2020
Former [2020/25]AL31.07.2019
AT31.07.2019
CZ31.07.2019
DK31.07.2019
EE31.07.2019
ES31.07.2019
FI31.07.2019
HR31.07.2019
IT31.07.2019
LT31.07.2019
LV31.07.2019
MC31.07.2019
NL31.07.2019
PL31.07.2019
RO31.07.2019
RS31.07.2019
SE31.07.2019
SK31.07.2019
TR31.07.2019
BG31.10.2019
NO31.10.2019
GR01.11.2019
PT02.12.2019
IS24.02.2020
Former [2020/24]AL31.07.2019
AT31.07.2019
DK31.07.2019
EE31.07.2019
ES31.07.2019
FI31.07.2019
HR31.07.2019
IT31.07.2019
LT31.07.2019
LV31.07.2019
MC31.07.2019
NL31.07.2019
PL31.07.2019
RO31.07.2019
RS31.07.2019
SE31.07.2019
TR31.07.2019
BG31.10.2019
NO31.10.2019
GR01.11.2019
PT02.12.2019
IS24.02.2020
Former [2020/23]AL31.07.2019
AT31.07.2019
DK31.07.2019
EE31.07.2019
ES31.07.2019
FI31.07.2019
HR31.07.2019
IT31.07.2019
LT31.07.2019
LV31.07.2019
NL31.07.2019
PL31.07.2019
RO31.07.2019
RS31.07.2019
SE31.07.2019
TR31.07.2019
BG31.10.2019
NO31.10.2019
GR01.11.2019
IS30.11.2019
PT02.12.2019
Former [2020/22]AL31.07.2019
AT31.07.2019
DK31.07.2019
EE31.07.2019
ES31.07.2019
FI31.07.2019
HR31.07.2019
LT31.07.2019
LV31.07.2019
NL31.07.2019
RS31.07.2019
SE31.07.2019
TR31.07.2019
BG31.10.2019
NO31.10.2019
GR01.11.2019
IS30.11.2019
PT02.12.2019
Former [2020/17]AL31.07.2019
AT31.07.2019
ES31.07.2019
FI31.07.2019
HR31.07.2019
LT31.07.2019
LV31.07.2019
NL31.07.2019
RS31.07.2019
SE31.07.2019
TR31.07.2019
BG31.10.2019
NO31.10.2019
GR01.11.2019
IS30.11.2019
PT02.12.2019
Former [2020/15]AL31.07.2019
AT31.07.2019
ES31.07.2019
FI31.07.2019
HR31.07.2019
LT31.07.2019
LV31.07.2019
NL31.07.2019
RS31.07.2019
SE31.07.2019
BG31.10.2019
NO31.10.2019
GR01.11.2019
IS30.11.2019
PT02.12.2019
Former [2020/12]AT31.07.2019
ES31.07.2019
FI31.07.2019
HR31.07.2019
LT31.07.2019
LV31.07.2019
NL31.07.2019
RS31.07.2019
SE31.07.2019
BG31.10.2019
NO31.10.2019
GR01.11.2019
IS30.11.2019
PT02.12.2019
Former [2020/11]AT31.07.2019
ES31.07.2019
FI31.07.2019
HR31.07.2019
LT31.07.2019
LV31.07.2019
NL31.07.2019
RS31.07.2019
SE31.07.2019
BG31.10.2019
NO31.10.2019
GR01.11.2019
PT02.12.2019
Former [2020/10]AT31.07.2019
FI31.07.2019
LT31.07.2019
NL31.07.2019
SE31.07.2019
BG31.10.2019
NO31.10.2019
PT02.12.2019
Former [2020/09]FI31.07.2019
LT31.07.2019
NL31.07.2019
NO31.10.2019
Former [2020/08]LT31.07.2019
NO31.10.2019
Documents cited:Search[A]EP0553770  (BOEHRINGER MANNHEIM GMBH [DE]) [A] 1-43;
 [X]WO9836278  (BETH ISRAEL HOSPITAL [US]) [X] 1-43 * p.7 par.1, p.9 par.1 *;
 [X]WO0042434  (PEVEC BERND [DE]) [X] 1-43 * pp.4 -6, p.8 par.2, p.10 par.1; claims; figures *;
 [X]EP1197754  (WANG TANG J [US]) [X] 1-43 * par.13-14, 23, 27, 29-30 *;
 [X]US2004029177  (NADAOKA MASATAKA [JP], et al) [X] 1-43 * p.10 col.1 *;
 [X]WO2004086042  (ANI BIOTECH OY [FI], et al) [X] 1-43* p.6 par.1; claims *;
 [X]WO2004095030  (KIMBERLY CLARK CO [US], et al) [X] 1-43 * p.10 l.24 - p.12 par.1 *;
 [X]US2006019404  (BLATT JOEL M [US], et al) [X] 1-43 * par.4,7, 18; p.5 *;
 [X]WO2008122796  (INVERNESS MEDICAL SWITZERLAND [CH], et al) [X] 1-43 * pp.4-5; claims *;
 [X]EP2031376  (INVERNESS MEDICAL SWITZERLAND [CH]) [X] 1-43 * par.48-49, figures *;
 [X]WO2009144507  (SPD SWISS PREC DIAGNOSTICS GMB [CH], et al) [X] 1-43 * p.6 penultimate paragraph - p.8 par.2; p.21 penultimate paragraph - p.22; claims *;
 [X]WO2011100462  (CHURCH & DWIGHT CO INC [US], et al) [X] 1-43 * par.114, 128-135, 140-154; claims *;
 [X]  - NAOYA OHMURA ET AL, "Combinational use of antibody affinities in an immunoassay for extension of dynamic range and detection of multiple analytes", ANALYTICAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, vol. 75, no. 1, doi:10.1021/AC020247, ISSN 0003-2700, (20030101), pages 104 - 110, (20021123), XP002631118 [X] 1-43 * abstract *

DOI:   http://dx.doi.org/10.1021/AC020247
International search[X]US6656745  (COLE FRANCIS X [US]);
 [Y]  - DI ANGELANTONIO ET AL., "Prognostic significance of admission levels of troponin I in patients with acute ischaemic stroke", J NEUROL NEUROSURG PSYCHIATRY, (2005), vol. 76, pages 76 - 81, XP055144334

DOI:   http://dx.doi.org/10.1136/jnnp.2004.041491
ExaminationEP0060700
 EP0465266
 US5968839
 WO2006065314
    - GANTELIUS J ET AL, "A lateral flow protein microarray for rapid determination of contagious bovine pleuropneumonia status in bovine serum", JOURNAL OF MICROBIOLOGICAL METHODS, ELSEVIER, AMSTERDAM, NL, vol. 82, no. 1, ISSN 0167-7012, (20100701), pages 11 - 18, (20100701), XP027265479
by applicantUS5290678
 US6177281
 US6461828
 US6780606
 WO2004086042
 US2005208576
 WO2007098184
 US7390674
 WO2009014787
 US7491551
 WO2010132453
    - SHARMA et al., "Cardiac Troponins", J. Clin. Pathol., (20040000), vol. 57, pages 1025 - 1026
    - "Antibodies: Key to a Robust Lateral Flow Immunoassay", BROWN, Lateral Flow Immunoassay, Humana Press, (20090000), page 60
    - RICHARD P. HOAGLAND, Molecular Probes Handbook
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.